A drug that is commonly used to treat eye diseases may soon be used to protect against dementia, new research suggests. The drug may also show promise in the treatment of other neurodegenerative ...

The overall rate of emergency room visits for older adults with Alzheimer's disease was 36.1 visits per 1,000 adults in ...

Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The ...

Earlier this year Nice decided not to fund the new ‘miracle’ Alzheimer’s drug on the NHS, but who makes that decision?

“In other diseases like cancer, treatments have become more effective, safer and cheaper over time and we hope to see similar progress in dementia. “With around 20 Alzheimer’s disease drugs in ...

Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds.

A new dementia drug candidate developed by domestic researchers has signed a technology export contract with overseas ...

Anchor] A candidate substance for a dementia treatment developed by domestic researchers is exported technology to overseas ...

NHS patients are set to miss out on new Alzheimer’s drugs, experts warn ...

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending ...

There was frustration in some corners of the media when it was announced that a new drug to slow the progression of Alzheimer ...

Dementia Australia, the national peak body that supports people living with dementia, said it is "disappointed" after the ...